Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Ruobing Ma"'
Autor:
Haibo Mou, Lanfang Yu, Qin Liao, Xuehua Hou, Yinfang Wu, Qiang Cui, Na Yan, Ruobing Ma, Lingjian Wang, Ming Yao, Kai Wang
Publikováno v:
BMC Cancer, Vol 18, Iss 1, Pp 1-5 (2018)
Abstract Background Cholangiocarcinoma, or bile duct cancer, is a gastrointestinal cancer with limited therapeutic options and a poor outcome. Studies have revealed that some major driver genes are associated with cholangiocarcinoma, but no targeted
Externí odkaz:
https://doaj.org/article/4e4d89fbace84cccbfe13ec68a73ad8a
Autor:
Ling Peng, Weijia Fang, Zhou Tong, Ruobing Ma, Kai Wang, Li-Ming Wu, Liping Wang, Wei Wu, Yi Zheng, Ming Yao, Lulu Liu, Peng Zhao, Hangyu Zhang, Weiqin Jiang
Publikováno v:
The Oncologist. 24:449-454
With the advent of next-generation sequencing (NGS) and precision medicine, investigators have determined that tumors from different tissue sources that have the same types of genetic mutations will have a positive response to the same targeted thera
Publikováno v:
Medicine
Rationale: Primary splenic angiosarcoma (PSA) is a rare mesenchymal malignancy of the splenic vascular origin often with a dismal prognosis. Genomic profile may provide evidence for the solution of therapy. Patient concerns: We reported a case of a 5
Autor:
Peng, Zhao, Ling, Peng, Wei, Wu, Yi, Zheng, Weiqin, Jiang, Hangyu, Zhang, Zhou, Tong, Lulu, Liu, Ruobing, Ma, Liping, Wang, Ming, Yao, Kai, Wang, Weijia, Fang, Liming, Wu
Publikováno v:
The oncologist. 24(4)
With the advent of next‐generation sequencing (NGS) and precision medicine, investigators have determined that tumors from different tissue sources that have the same types of genetic mutations will have a positive response to the same targeted the
Autor:
Lan-Fang Yu, Lingjian Wang, Yinfang Wu, Kai Wang, Ming Yao, Qiang Cui, Ruobing Ma, Hai-Bo Mou, Qin Liao, Na Yan, Xuehua Hou
Publikováno v:
BMC Cancer
BMC Cancer, Vol 18, Iss 1, Pp 1-5 (2018)
BMC Cancer, Vol 18, Iss 1, Pp 1-5 (2018)
Background Cholangiocarcinoma, or bile duct cancer, is a gastrointestinal cancer with limited therapeutic options and a poor outcome. Studies have revealed that some major driver genes are associated with cholangiocarcinoma, but no targeted therapies
Autor:
Kunpeng Bu, Zuping Lian, Xiangping Wang, Guoli Lv, Ruobing Ma, Qiang Cui, Ming Yao, Aodi Wang, Hui Chen, Youming Lei
Publikováno v:
Cancer Research. 79:2519-2519
Background: FGFR gene is a promising therapeutic target, and several inhibitors targeted FGFR have demonstrated clinical benefit in cancer patients, such as Erdafitinib in Metastatic Urothelial Cancer. However, the landscape of FGFR gene in Chinese p
Autor:
Hui Li, Xueqing Yao, Yun Guo, Ming Yao, Yang Lou, Tao Xiang, Yongchang Zhang, Shuo Mu, Kai Wang, Sen Zhang, Weibin Shu, Lei Mei, Zoltan Szallasi, Zusen Wang, Yu Wang, Qiang Cui, Ruobing Ma, Yong Li, Wei Zhao, Ting Deng
Publikováno v:
Cancer Research. 78:4613-4613
Background: Recent reports have demonstrated inferior outcomes for patients with right-sided colorectal cancer (RCC) compared to left-sided (LCC) as well as differences in treatment response based on disease sidedness. Molecular analyses provide a pa
Autor:
Ruobing Ma, Yuandong Wang, Lei Dai, Li Yang, Li Zhuang, Peng Zhao, Yigang Qian, Songfeng Yu, Honglin Guo, Ming Yao, Qiyong Li, Ming Wang
Publikováno v:
Journal of Clinical Oncology. 36:e13519-e13519
e13519Background: Cell cycle regulation plays a vital role in cancer development, and targeting the aberrant pathway using CDK4/6 inhibitors shows reliable efficacy in tumor suppression. Characteri...
Autor:
Xiaojian Liu, Ming Yao, Yuan Zhang, Weiwei Shi, Ruobing Ma, Jie Lin, Jing Hu, Yun Guo, Yu-An Dong, Honglin Guo
Publikováno v:
Journal of Clinical Oncology. 36:e15609-e15609
e15609Background: Adenomatous polyposis coli (APC) is a tumor suppressor gene whose inactivating mutation leads to inherited familial adenomatous polyposis and subsequently almost definitive early ...
Publikováno v:
Cancer Cell International
Objective The primary purpose of this study was to investigate the correlation between single nucleotide polymorphisms (SNPs) of ATP binding cassette superfamily G member 2 (ABCG2) and outcome of tyrosine kinase inhibitions (TKIs) therapy in Chinese